Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

Across 31 studies of patients with NMOSD, more than half of the patients included reported having sleep disturbances associated with their condition. 

High Rates of Depression, Anxiety, and Sleep Disturbances Found in NMOSD

Neurona Therapeutics’ NRTX-1001, a regenerative neural cell therapy derived from human stem cells, showed promise in potentially suppressing seizures in patients with drug-resistant mesial temporal lobe epilepsy.

NRTX-100 Shows Seizure Suppression in Preclinical Drug-Resistant Focal Epilepsy Models

A panel of experts provide commentary on a range of topics regarding the
integration of biosimilars in the management of multiple sclerosis, including the
supporting data behind these agents and how the clinical community can adapt.

Biosimilars Enter the Multiple Sclerosis Treatment Paradigm

Slideshows

Review the latest peer-reviewed articles dedicated to the multidisciplinary management of multiple sclerosis published in the International Journal of MS Care.

International Journal of MS Care: November/December 2023 Highlights

Videos

The director of the headache section at Cleveland Clinic detailed some of the emerging nonpharmacological preventive methods for migraine, as well as where research is headed following the explosion of CGRP-targeting therapies. [WATCH TIME: 6 minutes]

Expanding the Migraine Treatment Protocol Beyond CGRPs: Emad Estemalik, MD

Pharmacist and Director of Clinical Content and Resources on the Clinical Innovation and Strategy team at the National Multiple Sclerosis Society

With the first approved biosimilar entering the US treatment market, the time for clinicians to understand the coming era of therapies is now.

Acceptance of and Access to Biosimilars and Generics: The MS Treatment Landscape and Patient Engagement

Rebecca Whitney, associate director of Programs and Community Support at SRNA and mother of child with a rare neuroimmune disorder, provided thoughts on the importance of caregivers and the role they play in everyday life.

The Label of ‘Caregiver’

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

NMOSD

Narcolepsy

Ataxia

Parkinson Disease

AANEM 2023

CTAD 2023

MSMilan 2023

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

Authors

Haeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.

Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug Development